AVP may play an important role in the development of metabolic disease because it stimulates hepatic gluconeogenesis and glycogenolysis through V1aR [47, 48] and triggers release of both glucagon and insulin through V1bR in pancreatic islets [49]. The gene discussed is AVPR1A; the disease is metabolic disease.